Globotriaosylceramide
== Globotriaosylceramide ==
Globotriaosylceramide (Gb3), also known as ceramide trihexoside, is a glycosphingolipid consisting of a ceramide and three sugar molecules: two galactose units and one glucose unit. It is a member of the glycosphingolipid family, which are essential components of cell membranes and play a crucial role in cell signaling and interaction.
Structure[edit | edit source]
Globotriaosylceramide is composed of a hydrophobic ceramide backbone linked to a hydrophilic trisaccharide chain. The ceramide portion consists of a long-chain base (sphingosine) and a fatty acid, while the trisaccharide chain is made up of two galactose molecules and one glucose molecule.
Function[edit | edit source]
Gb3 is primarily found in the plasma membrane of cells, particularly in the kidney, heart, and nervous system. It is involved in various cellular processes, including cell adhesion, signal transduction, and the formation of lipid rafts. Gb3 also serves as a receptor for certain bacterial toxins, such as the Shiga toxin produced by Escherichia coli.
Clinical Significance[edit | edit source]
The accumulation of globotriaosylceramide in tissues is a hallmark of Fabry disease, a rare genetic disorder caused by mutations in the GLA gene that lead to a deficiency of the enzyme alpha-galactosidase A. This enzyme is responsible for breaking down Gb3, and its deficiency results in the progressive buildup of Gb3 in various organs, leading to symptoms such as pain, kidney dysfunction, heart disease, and stroke.
Diagnosis and Treatment[edit | edit source]
Diagnosis of Fabry disease typically involves measuring the activity of alpha-galactosidase A in blood or tissue samples, as well as genetic testing to identify mutations in the GLA gene. Treatment options include enzyme replacement therapy (ERT) with recombinant alpha-galactosidase A, which helps reduce Gb3 accumulation and alleviate symptoms. Other treatments may include pain management, kidney dialysis, and heart medications.
Related Pages[edit | edit source]
- Fabry disease
- Glycosphingolipid
- Alpha-galactosidase A
- GLA gene
- Shiga toxin
- Lipid raft
- Plasma membrane
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
